Keyphrases
Approved Drugs
25%
Autoimmune Disease
100%
Autoreactive T Cells
25%
Body Defence
25%
Copolymer-1
100%
Defense Mechanisms
25%
Dual Action
100%
Glatiramer Acetate
100%
Inflammatory Response
25%
Multiple Sclerosis Treatment
25%
Neurodegeneration
25%
Neurodegenerative Diseases
100%
Protective Autoimmunity
50%
Protective Effect
25%
Therapeutic Vaccine
25%
Vaccination
25%
Medicine and Dentistry
Autoimmune Disease
60%
Degenerative Disease
20%
Glatiramer
100%
Immunity
20%
Neurodegeneration
20%
Neurodegenerative Disorder
100%
Protective Autoimmunity
40%
Serositis
20%
T Cell
20%
Therapeutic Vaccine
20%
Treatment of Multiple Sclerosis
20%
Immunology and Microbiology
Autoimmune Disease
60%
Autoimmunity
40%
Glatiramer Acetate
100%
Immunity
20%
T Cell
20%
Treatment of Multiple Sclerosis
20%
Pharmacology, Toxicology and Pharmaceutical Science
Autoimmune Disease
60%
Degenerative Disease
20%
Glatiramer
100%
Inflammation
20%
Multiple Sclerosis
20%
Nerve Degeneration
20%
Therapeutic Vaccine
20%